(Q47802783)

English

Assessing the impact of chemotherapy-induced nausea and vomiting on patients' daily lives: a modified version of the Functional Living Index-Emesis (FLIE) with 5-day recall

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12827483

Assessing the impact of chemotherapy-induced nausea and vomiting on patients' daily lives: a modified version of the Functional Living Index-Emesis (FLIE) with 5-day recall (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12827483

0 references

1 reference

based on heuristic

inferred from title

author name string

A R Martin

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12827483

J D Pearson

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12827483

B Cai

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12827483

M Elmer

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12827483

K Horgan

5

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12827483

C Lindley

6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12827483

publication date

25 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12827483

Supportive Care in Cancer

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12827483

11

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12827483

8

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12827483

522-527

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12827483

Time-limit tests: estimating their reliability and degree of speeding

1 reference

https://pubmed.ncbi.nlm.nih.gov/12827483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin and emesis: aspects of treatment and a new trial for delayed emesis using oral dexamethasone plus ondansetron beginning at 16 hours after cisplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/12827483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ondansetron compared with granisetron in the prophylaxis of cyclophosphamide-induced emesis in out-patients: a multicentre, double-blind, double-dummy, randomised, parallel-group study. Emesis Study Group for Ondansetron and Granisetron in Breast Ca

1 reference

https://pubmed.ncbi.nlm.nih.gov/12827483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life consequences of chemotherapy-induced emesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12827483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/12827483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/12827483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12827483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral ondansetron in the prevention of chemotherapy-induced emesis in breast cancer patients. French Ondansetron Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12827483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients' estimation of overall treatment burden: why not ask the obvious?

1 reference

https://pubmed.ncbi.nlm.nih.gov/12827483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12827483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/12827483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A checklist for evaluating the usefulness of rating scales

1 reference

https://pubmed.ncbi.nlm.nih.gov/12827483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of oral ondansetron versus prochlorperazine in the prevention of emesis associated with cyclophosphamide-based chemotherapy and maintenance of health-related quality of life

1 reference

https://pubmed.ncbi.nlm.nih.gov/12827483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 reference

https://pubmed.ncbi.nlm.nih.gov/12827483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved control of emesis and quality of life with ondansetron in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12827483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of chemotherapy- and radiotherapy-induced emesis: results of Perugia Consensus Conference. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/12827483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of nausea and emesis during cancer chemotherapy. Discrepancies between antiemetic effect and well-being

1 reference

https://pubmed.ncbi.nlm.nih.gov/12827483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00520-003-0482-4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12827483

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12827483

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47802783&oldid=2208859691"